undefined undefined
NaN.000
NaN.00%
Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.05) per share which beat the analyst consensus estimate of $(1.06) by 0.94 percent. This is a 69.21 percent increase over losses of $(3.41) per share from the same
9分钟前
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing...
今天 14:15
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
05-09 17:01
北京时间2024年05月07日22时36分,诺瓦瓦克斯医药(NVAX.us)股票出现波动,股价急速下挫5.04%。截至发稿,该股报4.52美元/股,成交量18...
05-07 22:36
As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company (NYSE:DIS), Palantir Technologies...
05-05 20:00
Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update their COVID-19 vaccine formulations to reflect the currently dominant SARS-CoV-...
04-28 02:11
高盛涨4.2%,Q1营收超预期。特斯拉跌1.0%,被曝全球裁员超10%。Salesforce跌3.1%,Informatica跌2.4%,传双方并购交易接近尾声...
04-15 21:30
In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, expressed disappointment with the recent performance of Novavax stock and appointed two new directors to the company's board.
04-15 21:14
格隆汇4月15日|美国对冲基金Shah Capital建议Covid-19疫苗生产商Novavax任命两名新的独立董事Suresh Katta和Venka...
04-15 20:53